Blog Posts

Since 2000, students at the Community College of Philadelphia have been participating in a summer program at The Wistar Institute to learn the ins and outs of being a research technician. Graduates of this program have the opportunity to apprentice in a lab at Wistar or one of its partners to develop more specialized skills, and ultimately, the foundation for a life science career.

In 1979, at the dawn of the biotechnology era, The Wistar Institute was awarded the first of several patents for the production of monoclonal antibodies against tumors and influenza virus antigens, which would lay the foundation for the entire field of immunotherapy. Leveraging this important discovery and intellectual property, Centocor, an immunotherapy start-up company led by Dr.

For as far back as he can remember, Roger Malerba wanted to be a physician. He majored in biology at La Salle University and even shadowed doctors to learn more about orthopedic surgery, the specialty he planned to pursue.

Advancing High-Risk / High Reward Science

For more than a century, The Wistar Institute Cancer Center has led many of the major advances in cancer research and treatment. Wistar scientists were among the first to describe genetic abnormalities that are now recognized as the early-stage clues to cancer. Wistar scientists were the pioneers in monoclonal antibodies, paving the way for targeted therapies and immunotherapies that are – in most instances – the most effective cancer treatments.